Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion type Assertion NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_head.
- NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion wasGeneratedBy ECO_0000203 NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_provenance.
- NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion wasDerivedFrom befree-20140225 NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_provenance.
- NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion SIO_000772 15262134 NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_provenance.
- NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion evidence source_evidence_literature NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_provenance.
- NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_assertion description "[In patients with primary FIGO III carcinomas (n = 18), the overall-survival time (OST) was significantly prolonged with low MDR1/P-gp expression level (P = 0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270382.RAVjbSzgSCfZVzhoXj-hKlcJ3kn1iy2i27vvcD0_EOa-s130_provenance.